GE HealthCare to buy Sofie Biosciences for $945 million
GE HealthCare (GEHC) announced its intention to acquire Sofie Biosciences for $945 million in cash. The deal aims to bolster GE HealthCare's radiopharmaceutical business, enhancing its capabilities in manufacturing and distributing PET imaging drugs.